Immediate Impact

1 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
Atopic dermatitis
2025 Standout
2 intermediate papers

Works of Boyang Bian being referenced

Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010
2015
A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group
2010

Author Peers

Author Last Decade Papers Cites
Boyang Bian 104 69 40 61 19 352
Mikkel Zöllner Ankarfeldt 60 87 36 29 28 376
Sandra Lau 54 69 21 26 29 404
Olaf H. Klungel 83 62 18 46 12 365
Susanne Engel 38 39 26 43 20 302
Christine E. Hallgreen 154 64 8 20 28 355
Anne Catharina Brockhaus 88 45 29 17 11 390
Ulrik Hesse 65 36 23 18 16 403
Eliana Vieira Santucci 63 81 59 56 15 366
Kenneth Hornbuckle 28 30 27 56 23 322
Lorenzo Hess 78 22 13 49 15 339

All Works

Loading papers...

Rankless by CCL
2026